Marimed (MRMD) Income from Non-Controlling Interests (2016 - 2026)
Marimed (MRMD) reported Income from Non-Controlling Interests of $18000.0 for Q1 2026, down 43.75% year-over-year from $32000.0 in Q1 2025, and up 280.0% quarter-over-quarter from -$10000.0 in Q4 2025.
Marimed (MRMD) Income from Non-Controlling Interests (2016 - 2026) Analysis & Trends
Marimed (MRMD) has 11 years of Income from Non-Controlling Interests data on file, last reported at $18000.0 in Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at $18000.0, down 43.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $14000.0 (down 77.78% YoY), and the FY2025 annual result was $28000.0, down 24.32% from the prior year.
- Income from Non-Controlling Interests grew to $18000.0 in Q1 2026 per MRMD's latest filing, from -$10000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $73000.0 in Q2 2022 and troughed at -$19000.0 in Q1 2023.
- A 5-year average of $14882.4 and a median of $12000.0 in 2024 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2023 and 2025: Income from Non-Controlling Interests soared 650.0% in 2023, then sank 433.33% in 2025.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $4000.0 in 2022, then soared by 650.0% to $30000.0 in 2023, then plunged by 90.0% to $3000.0 in 2024, then slumped by 433.33% to -$10000.0 in 2025, then jumped by 280.0% to $18000.0 in 2026.
- Business Quant data shows MRMD's Income from Non-Controlling Interests at $18000.0 in Q1 2026, -$10000.0 in Q4 2025, and $7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Marimed | - | - | 15.28 Mn | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | -10,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | -19,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | 110,000.00 |
| Sep 30, 2021 | 103,000.00 |
| Jun 30, 2021 | 96,000.00 |